Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
Live Science on MSN
It matters what time of day you get cancer treatment, study suggests
Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.
The grant program run by the German Federal Ministry of Education and Research (BMBF) supports SMEs working on innovative projects in biomedicine Non-dilutive support for planned phase 2 trial now ...
Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...
Working the night shift, frequently flying across time zones or keeping an irregular sleep schedule does more than just leave ...
A Florida doctor who treats blood cancers writes that, too often, his patients’ care is determined by health insurers’ profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback